Metacam for dogs and cats: formulations and risks

Metacam identifies several meloxicam-based presentations. Products, concentrations and indications must not be transferred from one species to another.

There is no single product sheet

Solutions, suspensions and other presentations may have different target species and indications. The dog product must not be used as a reference for cats or vice versa.

The article does not publish a universal dosage.

Veterinary assessment

Hydration status, kidney or liver function, the gastrointestinal system and concurrent treatments may influence safety. The prescription considers the individual animal.

Different anti-inflammatory medicines must not be combined or substituted without advice.

Signs to report

Vomiting, diarrhoea, reduced appetite, dark faeces, changes in urination or lethargy require prompt veterinary contact.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• European Medicines Agency — Metacam - EPAR (accessed 24/07/2026)
• Union Product Database — Veterinary medicines authorised in the European Union (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.